Home

Natco Pharma Ltd EPS

Image

Natco Pharma Ltd

NSE: NATCOPHARM

EPS

₹ 104.13

Last updated on: Apr 25, 2025

Key Highlights

  • The Earning per Share of Natco Pharma Ltd is ₹ 104.13 as of 25 Apr 25 .
  • The earning per share of Natco Pharma Ltd changed from ₹ 23.26 to ₹ 7.43 over 7 quarters. This represents a CAGR of -47.91% .

Historical Earning per Share of Natco Pharma Ltd

No data available

* All values are in

Company Fundamentals for Natco Pharma Ltd

Market Cap

15,934 Cr

EPS

104.1

P/E Ratio (TTM)

8.5

P/B Ratio (TTM)

2.2

Day’s High

922.05

Day’s Low

873.0

DTE

0.0

ROE

27.2

52 Week High

1638.35

52 Week Low

660.05

ROCE

32.3

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Apr 2025889.65
24 Apr 2025903.65
23 Apr 2025845.15
22 Apr 2025839.4
21 Apr 2025829
17 Apr 2025826.85
16 Apr 2025827.1
15 Apr 2025804.65
11 Apr 2025775.35
09 Apr 2025746.85

SWOT Analysis Of Natco Pharma Ltd

Strength

4

che

Weakness

3

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Natco Pharma Ltd

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

15,935

Asset Value

Value addition

3.2 X

3,808

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Natco Pharma Ltd15934
Sun Pharmaceutical Industries Ltd428725
Divis Laboratories Ltd159525
Cipla Ltd123202
Torrent Pharmaceuticals Ltd109514
Mankind Pharma Ltd105276

Historical Market Cap of Natco Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Natco Pharma Ltd News Hub

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad

Read more

04 Sept 24

Natco Pharma fixes record date for second interim dividend

Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The

Read more

12 Aug 24

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2

Read more

12 Aug 24

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30

Read more

12 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

June 2023

TranscriptPPT

June 2022

TranscriptPPT

July 2021

TranscriptPPT

FAQs for EPS of Natco Pharma Ltd

What is the EPS of Natco Pharma Ltd stock?

The Earnings Per Share (EPS) of Natco Pharma Ltd is 104.13. An EPS is the amount of net income attributed to each share of a common stock.

How is Natco Pharma Ltd EPS calculated?

The EPS of Natco Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Natco Pharma Ltd report its EPS?

Natco Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Natco Pharma Ltd EPS?

Factors that influence the EPS of Natco Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Natco Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Natco Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions